Labcorp Holdings Inc. LH
309.64
0.69
0.22%
as of 25 Sep
- Market cap
- $21.9B
- P/E
- 25.4×
Follow LH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
23.01 | 23.49 | 23.80 | 27.98 |
+8 more quarters Free account |
P/S ratio |
1.59 | 1.55 | 1.50 | 1.73 | |
P/FCF ratio |
22.16 | 17.41 | 19.40 | 19.12 | |
P/Operating CF |
51.35 | 114.67 | 33.98 | 61.61 | |
P/B ratio |
2.66 | 2.52 | 2.42 | 2.74 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.08 | 1.98 | 1.91 | 2.15 | |
EV/EBITDA |
13.60 | 13.18 | 12.90 | 14.69 | |
EV/Operating CF |
18.20 | 15.46 | 16.24 | 16.39 | |
EV/FCF |
28.88 | 22.23 | 24.77 | 23.70 | |
Quick Ratio |
1.25 | 1.30 | 0.99 | 1.09 | |
Current Ratio |
1.80 | 1.73 | 1.42 | 1.55 | |
Net Debt/EBITDA |
9.16 | 8.87 | 10.48 | 8.01 | |
Debt/Assets |
31.94% | 30.89% | 27.99% | 28.18% | |
Debt/Equity |
0.69 | 0.68 | 0.60 | 0.59 | |
Asset Turnover |
0.78 | 0.77 | 0.76 | 0.75 | |
Operating CF/Net income |
1.49 | 0.69 | 3.73 | 1.48 | |
Capex/Depreciation |
(0.72) | (0.65) | (0.69) | (0.62) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.47% | 15.58% | 15.32% | 15.50% | |
Intangible Assets out of Total Assets |
0.58 | 0.55 | 0.56 | 0.56 | |
Share Based Compensation of Revenue |
0.94% | 0.90% | 0.84% | 0.82% | |
Graham Net Nets |
(0.27) | (0.26) | (0.28) | (0.23) | |
Graham Number |
169.84 | 164.65 | 156.75 | 155.43 | |
Earnings Yield |
4.35% | 4.26% | 4.20% | 3.57% | |
Free Cash Flow Yield |
4.51% | 5.74% | 5.15% | 5.23% | |
Revenue per Share |
45.67 | 42.98 | 42.26 | 42.88 | |
Operating CF per Share |
5.45 | 2.33 | 7.38 | 4.66 | |
Capex per Share |
(1.59) | (1.38) | (1.44) | (1.27) | |
Free Cash Flow per Share |
3.87 | 0.95 | 5.95 | 3.39 | |
Cash per Share |
1.74 | 11.92 | 6.40 | 7.20 | |
Shareholders Equity per Share |
105.35 | 106.06 | 103.60 | 104.66 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
105.35 | 106.06 | 103.60 | 104.66 | |
Free Cash Flow |
315.80 | 78.30 | 494.80 | 281.60 | |
Working Capital |
1,690.30 | 1,917.80 | 1,197.00 | 1,449.60 | |
Capital Expenditures |
(129.70) | (113.20) | (119.40) | (105.60) | |
Net Current Asset Value |
(6,110.60) | (5,799.70) | (5,752.40) | (5,485.90) | |
EV/EBIT |
19.92 | 19.47 | 19.25 | 22.17 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | |
Net Profit Margin |
8.01% | 7.85% | 4.68% | 7.33% | |
Price to Operating Income |
15.29 | 15.25 | 15.07 | 17.89 | |
| Other line items | |||||
Average Receivables |
2,390.75 | 2,362.50 | 2,178.85 | 2,245.00 | |
Average Payables |
740.75 | 706.80 | 858.30 | 664.70 | |
Average Inventory |
535.15 | 493.00 | 513.95 | 502.30 | |
Average Assets |
18,296.10 | 18,345.45 | 18,385.85 | 18,437.05 | |
Average Common Equity |
8,539.75 | 8,518.00 | 8,336.00 | 8,433.55 |
Columns are period end dates